DCs will be involved in intersectoral and
transnational secondments according to the following tentative scheme:
DC | Recruiting Beneficiary | Secondment 1 | Secondment 2 |
|---|---|---|---|
01 | University in Milan | GlycoUniverse | CICbiomaGUNE |
02 | University in Milan | University of Florence | GlycoUniverse |
03 | University of Florence | National Research Council, SCITEC Institute | Instituto de Salud CARLOS III |
04 | Max Planck Institute of Colloids and Interfaces | University of Florence | Aarhus University |
05 | GlycoUniverse | Max Planck Institute of Colloids and Interfaces | Institut National de la Santé et de la Recherche Médicale – INSERM |
06 | CICbiomaGUNE | University in Milan | Attana AB |
07 | Aarhus University | Max Planck Institute of Colloids and Interfaces | CICbiomaGUNE |
08 | Aarhus University | Institut National de la Santé et de la Recherche Médicale – INSERM | Fratagene Therapeutics |
09 | Institut National de la Santé et de la Recherche Médicale – INSERM | Instituto de Salud CARLOS III | Attana AB |
10 | Instituto de Salud CARLOS III | Aarhus University | National Research Council, SCITEC Institute |
